Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aqua Bio Technology ASALTS:0I8C 30 EV-to-EBITDA is 101.44 as of Sep. 02, 2026, which is 8645% above its 10-year median of 1.16. GuruFocus rates LTS:0I8C with a GF Score™ of 30/100 and a GF Value™ of kr2.89 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 402 Biotechnology companies, Aqua Bio Technology ASA ranks worse than 90.55% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Aqua Bio Technology ASA's enterprise value is kr145.16 Mil.
Aqua Bio Technology ASA's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was kr1.43 Mil. Therefore, Aqua Bio Technology ASA's EV-to-EBITDA for today is 101.44.
The historical rank and industry rank for Aqua Bio Technology ASA's EV-to-EBITDA or its related term are showing as below:
LTS:0I8C'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -34.2 Med: 1.16 Max: 102.95
Current: 101.44
During the past 13 years, the highest EV-to-EBITDA of Aqua Bio Technology ASA was 102.95. The lowest was -34.20. And the median was 1.16.
LTS:0I8C's EV-to-EBITDA is ranked worse than 90.55% of 402
companies
in the Biotechnology industry
Industry Median: 13.91
vs LTS:0I8C: 101.44
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Aqua Bio Technology ASA (LTS:0I8C) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Aqua Bio Technology ASA's PE Ratio (TTM) for today is calculated as:
Aqua Bio Technology ASA's share price for today is kr5.10.
Aqua Bio Technology ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-3.767.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0I8C vs VRTX, REGN, MRNA: EV-to-EBITDA Comparison
For the Biotechnology subindustry, Aqua Bio Technology ASA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aqua Bio Technology ASA EV-to-EBITDA vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aqua Bio Technology ASA's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Aqua Bio Technology ASA's EV-to-EBITDA falls into.
Aqua Bio Technology ASA's current Enterprise Value is kr145.16 Mil.
Aqua Bio Technology ASA's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.43 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aqua Bio Technology ASA (LTS:0I8C) has a EV-to-EBITDA of 101.44 as of Sep. 02, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Aqua Bio Technology ASA. This is 8645% above median its historical median of 1.16. According to the industry distribution chart, Aqua Bio Technology ASA ranks #364 out of 402 companies in the Biotechnology industry, placing it in the top 90.5%.
Is Aqua Bio Technology ASA's EV-to-EBITDA too high?
Aqua Bio Technology ASA's current EV-to-EBITDA of 101.44 is 8645% above median its 10-year median of 1.16. The Biotechnology industry median EV-to-EBITDA is 13.91. Aqua Bio Technology ASA's value of 101.44 is 629.3% above this industry median. Based on the distribution chart, Aqua Bio Technology ASA ranks #364 out of 402 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Aqua Bio Technology ASA has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aqua Bio Technology ASA's EV-to-EBITDA compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Aqua Bio Technology ASA ranks #364 out of 402 companies for EV-to-EBITDA. This places Aqua Bio Technology ASA in the lower half of its industry. The industry median EV-to-EBITDA is 13.91. Aqua Bio Technology ASA's value of 101.44 is 629.3% above this benchmark. While the company's 10-year median is 1.16 vs. the industry median of 13.91, Aqua Bio Technology ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Biotechnology company?
The median EV-to-EBITDA among Biotechnology companies is 13.91, based on 402 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aqua Bio Technology ASA's current EV-to-EBITDA of 101.44 is 629.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Aqua Bio Technology ASA. For the Biotechnology industry, the median EV-to-EBITDA is 13.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aqua Bio Technology ASA's current EV-to-EBITDA is 101.44, which is 8645% above median its own 10-year median of 1.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aqua Bio Technology ASA stock overvalued right now?
Based on GuruFocus' analysis, Aqua Bio Technology ASA (LTS:0I8C) is currently considered Significantly Overvalued. The stock's GF Value™ is kr2.89, compared to a current price of kr5.10 — trading 76.5% above its estimated fair value. The current EV-to-EBITDA is 101.44, which is 8645% above median its 10-year median of 1.16 and 629.3% above the Biotechnology industry median of 13.91. Aqua Bio Technology ASA's overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Aqua Bio Technology ASA (LTS:0I8C), the current EV-to-EBITDA is 101.44 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aqua Bio Technology ASA (LTS:0I8C) Overvalued in 2026?
Based on GuruFocus' analysis, Aqua Bio Technology ASA stock appears to be overvalued.
The current stock price of kr5.10 is trading 76.5% above its estimated GF Value™ of kr2.89.
GuruFocus considers Aqua Bio Technology ASA to be Significantly Overvalued.
Key valuation signals for LTS:0I8C:
EV-to-EBITDA: 101.44 (8645% above median its 10-year median of 1.16)
GF Value™: kr2.89 vs. price of kr5.10 (76.5% above fair value)
Industry Position: 629.3% above the Biotechnology median (#364 of 402)
No single metric tells the full story. See the LTS:0I8C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aqua Bio Technology ASA develops, produces and markets active ingredients for the personal care industry. It creates products for personal care, healthcare, and cosmetics with the help of marine biotechnology. ABT's brands include Moana-Organic skin care and Cuvget-Arctic skin care.
30GF Score
Get the complete analysis for LTS:0I8C
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0I8C has been successfully added to your 
